Full Text
PAM16- COST IMPACT OF COX-2 INHIBITORS IN A MANAGED CARE PLAN- IMPLICATIONS FOR FORMULARY DECISION-MAKING

Abstract

Authors

DE Atherly DS Fullerton LL Sturm A Bryant SD Sullivan

Back to Volume 4, Issue 2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×